Advises and executes on all aspects of federal advocacy strategies for Fortune 500 companies and large trade associations in a range of sectors including technology, retail, health care, beverage, and chemicals. Manages the strategy development and execution for multi-sectoral federal advocacy coalitions in a variety of issues.

An appointee of President Obama, managed a staff of nearly thirty career government officials dedicated to promoting exports of and investments in a broad cross-section of U.S. industries including textiles, apparel, home furnishings, processed foods, distilled spirits, recreational transportation, cosmetics, and chemicals. I served as the lead Department of Commerce negotiator on the Trans-Pacific Partnership’s Textiles and Apparel chapter, participating in multiple negotiating rounds with 11 TPP partner countries. The chapter would have governed more than $31 billion in U.S. textile and apparel exports and imports. Trade associations for both the domestic manufacturers and brand importers endorsed the agreement after its completion. In support of the Administration’s trade agenda, I gave on-the-record interviews and delivered more than a dozen presentations at trade shows, conferences, White House panels, small business roundtables, and universities.

Drafted, introduced, secured endorsements, held a subcommittee hearing, and passed through the Senate the Newborn Screening Saves Lives Reauthorization Act. President Obama signed the bill into law in December 2014. For this work, the Rare Disease Legislative Advocates nominated me for its legislative advocacy award.

Advised and supported Senator Hagan on international trade policy including by establishing her as the leading voice in the Senate for strong textiles rules of origin in the TPP, crafting a bill to incentivize the manufacture of textiles in the United States, and supported the consideration of three free trade agreements and a miscellaneous tariff bill. Developed legislative and communication strategies in coordination with other moderate Senate Democrats, Senate Democratic leadership, and the White House to handle the first open enrollment period of the Affordable Care Act. Negotiated with the leadership of the Senate HELP Committee, the FDA, and the pharmaceutical industry for inclusion in the FDA Safety and Innovation Act provisions to expand the accelerated approval pathway for new drug reviews. For this work, Senator Hagan received the Legislator of the Year award from BIO and the National Health Leadership Award from the National Organization of Rare Disorders.

Advised Rep. Israel on: health care during consideration of the Affordable Care Act; financial services during debate on the Dodd-Frank Wall Street Reform Act; and taxes during consideration of legislation to extend the Bush tax cuts. Supported Rep. Israel’s work for the House Appropriations Committee including reviewing, advocating for, and securing Congressionally-directed spending requests. Drafted amendments, bills, briefing memos, speeches, op-eds, letters to the editor, and vote recommendations